期刊文献+

链脲佐菌素致大鼠高血糖模型的实验研究 被引量:22

Study on the diabetic model induced by streptozocin in Wistar rats
下载PDF
导出
摘要 目的探讨链脲佐菌素(streptozocin,STZ)所致Wistar大鼠高血糖稳定模型的最佳实验条件。方法应用讹腹腔注射制备大鼠高血糖模型,计算成模率和死亡率。结朵采用一次给药法,分为不同剂量组(40mg/kg;50mg/kg;60mg/kg),其中50mg/ks剂量组成模率较好。采用两次给药法,第一次给予10mg/kg,隔1天分别给予以下剂量(40mg/kg,50mg/kg,60mg/kg),其中第一次10mg/kg,第二次50ms/ks剂量组成模率最高。两次给药法相对应剂量组成模率比一次给药法高。日照时间对成模率及死亡率均有影响。日照时间短,成模率明显降低,而且死亡率明显增高。结论用STZ制备糖尿病模型是一种稳定可靠的方法。实验选取雄性Wistar大鼠体重190~220g,在日照时间充足的条件下饲养。给药方式采取两步给药法,剂量为10mg/ks,隔1天给予50mg/kg,其成模率最高。 Objective To explore th.e optimal experimental conditions of diabetic animal model induced by streptozocin in Wistar rats. Methods Administering streptozocin intraperitoneally to establish high glucose rats animal model. The incidence and mortality of diabetes model were measured. Results On the condition of onestep treatment(40mg/kg; 50mg/kg; 60mg/kg), the incidence of diabetes in dosage of 50mg/kg was higher. On the condition of two-step treatment (10mg/kg in the first day, administering dosages as same as one-step treatment in the third day),the incidence of diabetes in dosage( 10mg/kg at the first time,50mg/kg at the second time) was the highest. Incidence of diabetes in two-step treatment was higher compared with one-step treatment in corresponding dosage group. Sunshine time had effect on both the incidence and mortality of diabetes. When the rats were exposed to sunshine in shorter time, the incidence of diabetes was apparently decsreased and the mortality was increased. Conclusion The animal model of diabetes induced by streptozocin is steady and reliable .On the condition of two-step treatment (10mg/kg in the first day and 50mg/kg in the third day) ,male wistar rats weighting 190 - 220g and exposing to enough sunshine more,the incidence of diabetes is the highest.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2006年第4期272-274,共3页 Journal of Harbin Medical University
基金 国家自然科学基金资助项目(30371647)
关键词 链脲佐菌素 两步给药法 糖尿病模型 大鼠 streptozocin two-step treatment diabetic model rats
  • 相关文献

参考文献4

  • 1黄波,刘学政,庞东渤.不同途径注射链脲佐菌素致大鼠糖尿病模型的研究[J].锦州医学院学报,2003,24(1):19-21. 被引量:57
  • 2张均田.现代药理试验方法[M].北京:北京医科大学、中国协和医科大学联合出版社,1998.1425-1452.
  • 3Rackiersn N, Rackictan ML, Nackami MR. Studies on diabetogenic action of streptozotozin [J]. Cancer Chemotherapy Reports, 1993,29: 91-95.
  • 4Bailes BK. Diabetes mellitus and its chronic ucomplications [ J ].AORNNGJ, 2002,76(2) : 266-276.

二级参考文献5

  • 1于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 2魏泓.医学实验动物学.四川科学技术出版社,1992.347-349.
  • 3Rackietan N, Rackietan ML, Nadkarni MR. Studies on diabetogenic action of streptozotozin. Cancer Chemotherapy Reports,1993, 29: 91~95.
  • 4赵凌云 钟成元 戴保民.链脲佐菌素诱发糖尿病大鼠模型[J].四川医学院学报,1985,164:289-291.
  • 5Junod A, Lamber AE Orci L, et al. Studys of the diabetogenic actionof streptozotocin. PTOC Soc Exp BiolmED, 1967, 125:201 ~203.

共引文献70

同被引文献219

引证文献22

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部